Alkim Alkali Kimya A.S.(TR:ALKIM)
₺10.77+0.13 (+1.22%)
TR:ALKIM
Alkim Alkali Kimya A.S. financials statements
₺10.77
At close:+0.13 (+1.22%)
Alkim Alkali Kimya A.S. (ALKIM) Ratios
Alkim Alkali Kimya A.S. Ratios
TR:ALKIM's free cash flow for Q3 2026 was ₺-182.30M. For the 2026 fiscal year, TR:ALKIM's free cash flow was decreased by ₺-164.01M and operating cash flow was ₺-18.29M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 2.52 | 2.64 | 1.99 | 2.55 |
| Quick Ratio | 0.91 | 1.36 | 1.57 | 1.20 | 1.77 |
| Cash Ratio | 0.19 | 0.54 | 0.76 | 0.59 | 1.01 |
| Solvency Ratio | -0.08 | 0.06 | 0.51 | 0.70 | 0.66 |
| Operating Cash Flow Ratio | 0.35 | 0.26 | 1.26 | 0.26 | 1.10 |
| Short-Term Operating Cash Flow Coverage | 3.03 | 6.51 | 10.17 | 3.07 | 13.72 |
| Net Current Asset Value | ₺ 763.89M | ₺ 1.21B | ₺ 1.18B | ₺ 818.73M | ₺ 432.43M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.03 | 0.03 | 0.06 | 0.07 |
| Debt-to-Equity Ratio | 0.06 | 0.04 | 0.04 | 0.10 | 0.11 |
| Debt-to-Capital Ratio | 0.05 | 0.03 | 0.03 | 0.09 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.03 | 0.00 | 0.05 | 0.07 |
| Financial Leverage Ratio | 1.48 | 1.37 | 1.38 | 1.58 | 1.72 |
| Debt Service Coverage Ratio | 0.61 | 1.08 | 4.07 | 16.82 | 11.49 |
| Interest Coverage Ratio | 3.04 | 24.61 | 36.69 | 237.38 | 1336.18 |
| Debt to Market Cap | 0.04 | 0.02 | 0.04 | 0.04 | 0.06 |
| Interest Debt Per Share | 0.97 | 0.49 | 0.73 | 0.77 | 0.51 |
| Net Debt to EBITDA | -0.07 | -2.06 | -1.26 | -0.23 | -0.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.98% | 14.17% | 19.79% | 25.45% | 27.74% |
| EBIT Margin | 2.76% | -0.67% | 5.91% | 19.92% | 32.30% |
| EBITDA Margin | 7.97% | 3.70% | 9.36% | 22.68% | 34.51% |
| Operating Profit Margin | 2.76% | 10.27% | 15.24% | 24.35% | 39.49% |
| Pretax Profit Margin | -3.02% | -1.08% | 5.49% | 13.25% | 32.30% |
| Net Profit Margin | -8.01% | -2.91% | 6.73% | 3.71% | 22.63% |
| Continuous Operations Profit Margin | -8.43% | -3.51% | 10.37% | 5.50% | 26.01% |
| Net Income Per EBT | 265.15% | 268.72% | 122.60% | 27.96% | 70.06% |
| EBT Per EBIT | -109.58% | -10.55% | 36.02% | 54.43% | 81.79% |
| Return on Assets (ROA) | -6.50% | -2.80% | 7.65% | 11.40% | 21.57% |
| Return on Equity (ROE) | -9.60% | -3.83% | 10.57% | 18.06% | 37.18% |
| Return on Capital Employed (ROCE) | 2.91% | 12.15% | 21.94% | 120.82% | 52.91% |
| Return on Invested Capital (ROIC) | 2.81% | 12.04% | 21.23% | 86.87% | 41.26% |
| Return on Tangible Assets | -6.51% | -2.81% | 7.66% | 11.42% | 21.62% |
| Earnings Yield | -7.40% | -2.39% | 10.61% | 6.77% | 19.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.09 | 7.99 | 10.17 | 6.63 | 4.58 |
| Payables Turnover | 4.04 | 5.22 | 6.20 | 7.64 | 3.65 |
| Inventory Turnover | 3.72 | 3.82 | 4.04 | 3.67 | 3.07 |
| Fixed Asset Turnover | 1.36 | 1.88 | 2.80 | 15.78 | 4.19 |
| Asset Turnover | 0.81 | 0.96 | 1.14 | 3.08 | 0.95 |
| Working Capital Turnover Ratio | 4.17 | 3.60 | 4.28 | 9.20 | 2.49 |
| Cash Conversion Cycle | 79.54 | 71.15 | 67.43 | 106.87 | 98.62 |
| Days of Sales Outstanding | 71.72 | 45.66 | 35.90 | 55.07 | 79.71 |
| Days of Inventory Outstanding | 98.20 | 95.43 | 90.44 | 99.58 | 118.87 |
| Days of Payables Outstanding | 90.38 | 69.94 | 58.91 | 47.78 | 99.96 |
| Operating Cycle | 169.92 | 141.09 | 126.34 | 154.65 | 198.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.69 | 0.77 | 6.28 | 1.16 | 2.43 |
| Free Cash Flow Per Share | -1.11 | -1.51 | 5.41 | 0.39 | 1.46 |
| Dividend Paid and CapEx Coverage Ratio | 0.60 | 0.34 | 2.80 | 0.68 | 1.29 |
| Capital Expenditure Coverage Ratio | 0.60 | 0.34 | 7.21 | 1.50 | 2.50 |
| Operating Cash Flow Coverage Ratio | 2.08 | 1.80 | 10.17 | 1.57 | 4.80 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.05 | 0.23 | 0.03 | 0.33 |
| Free Cash Flow Yield | -6.03% | -7.91% | 31.73% | 1.98% | 17.29% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.53 | -42.31 | 9.41 | 10.26 | 5.12 |
| Price-to-Sales (P/S) Ratio | 1.08 | 1.22 | 0.63 | 0.55 | 1.15 |
| Price-to-Book (P/B) Ratio | 1.30 | 1.60 | 1.00 | 2.67 | 1.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -16.58 | -12.64 | 3.15 | 50.62 | 5.78 |
| Price-to-Operating Cash Flow Ratio | 10.92 | 24.68 | 2.71 | 16.93 | 3.47 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.34 | -1.80 | 0.65 | 0.21 |
| Enterprise Value Multiple | 13.51 | 30.89 | 5.53 | 2.19 | 2.66 |
| Enterprise Value | 5.49B | 5.36B | 2.08B | 2.66B | 1.01B |
| EV to EBITDA | 13.51 | 30.89 | 5.53 | 2.19 | 2.66 |
| EV to Sales | 1.08 | 1.14 | 0.52 | 0.50 | 0.92 |
| EV to Free Cash Flow | -16.50 | -11.85 | 2.57 | 45.81 | 4.60 |
| EV to Operating Cash Flow | 10.86 | 23.13 | 2.21 | 15.32 | 2.76 |
| Tangible Book Value Per Share | 15.05 | 12.62 | 18.26 | 8.30 | 4.90 |
| Shareholders’ Equity Per Share | 14.18 | 11.88 | 17.10 | 7.34 | 4.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.79 | -2.24 | -0.31 | 0.24 | 0.19 |
| Revenue Per Share | 17.00 | 15.63 | 26.84 | 35.77 | 7.31 |
| Net Income Per Share | -1.36 | -0.45 | 1.81 | 1.33 | 1.65 |
| Tax Burden | 2.65 | 2.69 | 1.23 | 0.28 | 0.70 |
| Interest Burden | -1.10 | 1.63 | 0.93 | 0.67 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.10 | 0.08 | 0.03 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.24 | -1.41 | 3.47 | 0.26 | 1.47 |
Currency in TRY

